No connection

Search Results

ACU

NEUTRAL
$43.48 Live
Acme United Corporation · AMEX
Target $53.0 (+21.9%)
$35.5 52W Range $47.31

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 24, 2026
Market cap
$165.58M
P/E
18.74
ROE
9.1%
Profit margin
5.2%
Debt/Equity
0.24
Dividend yield
1.41%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
ACU presents a dichotomy between a rock-solid balance sheet and deteriorating short-term operational momentum. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the absence of an Altman Z-Score is offset by an exceptionally low Debt/Equity ratio (0.24) and a high Current Ratio (4.21). While the stock is fairly valued—trading between its Graham Number ($40.16) and Intrinsic Value ($48.95)—the recent Q/Q EPS collapse of -47.8% and a bearish technical trend (0/100) suggest significant near-term headwinds.

Key Strengths

Exceptional liquidity with a Current Ratio of 4.21
Very low leverage (Debt/Equity of 0.24)
Conservative dividend payout ratio (25.30%)
Low Price-to-Sales ratio (0.84) suggesting valuation support
Strong 3-year price appreciation (+72.4%)

Key Risks

Severe recent earnings contraction (-47.8% Q/Q EPS growth)
Bearish technical trend (0/100 score)
Low Piotroski F-Score (4/9) indicating stagnant operational efficiency
Modest revenue growth (3.40% YoY) in a competitive sector
High reliance on a single analyst's target price ($53.00)
AI Fair Value Estimate
Based on comprehensive analysis
$44.5
+2.3% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
60
Strong
Value
75
Future
40
Past
65
Health
70
Dividend
50
AI Verdict
Stable but Stagnant
Key drivers: Strong balance sheet, Recent earnings miss, Fair valuation
Confidence
80%
Value
75/100

Ref P/E 18.74, PEG 1.54, Graham Number $40.16

Positives
  • P/S ratio < 1.0
  • Price is near Graham Number
Watchpoints
  • Trading slightly above defensive fair value
Future
40/100

Ref Growth rates and recent earnings surprises

Positives
  • Positive YoY earnings growth (9.4%)
Watchpoints
  • Sharp Q/Q EPS decline
  • Low revenue growth
Past
65/100

Ref Historical price performance and EPS surprises

Positives
  • Strong 3Y return (+72.4%)
Watchpoints
  • Inconsistent quarterly earnings track record
Health
70/100

Ref Piotroski F-Score and Liquidity ratios

Positives
  • Very low Debt/Equity
  • High Current Ratio
Watchpoints
  • Piotroski F-Score is only 4/9
Dividend
50/100

Ref Yield 1.41%, Payout 25.30%

Positives
  • Low payout ratio ensures sustainability
Watchpoints
  • Low yield (1.41%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$43.48
Analyst Target
$53.0
Upside/Downside
+21.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ACU and closest competitors.

Updated 2026-04-23
ACU
Acme United Corporation
Primary
5Y
+4.5%
3Y
+72.4%
1Y
+4.1%
6M
+12.8%
1M
-2.0%
1W
-3.3%
SKI
The Beauty Health Company
Peer
5Y
-90.8%
3Y
-93.3%
1Y
+7.9%
6M
-36.1%
1M
-22.6%
1W
+1.7%
HFF
HF Foods Group Inc.
Peer
5Y
-70.7%
3Y
-47.9%
1Y
-47.4%
6M
-13.3%
1M
+10.6%
1W
+3.0%
BRC
BRC Inc.
Peer
5Y
-93.9%
3Y
-84.9%
1Y
-67.1%
6M
-53.2%
1M
-21.5%
1W
-3.1%
ISP
Ispire Technology Inc.
Peer
5Y
-76.8%
3Y
-76.2%
1Y
-50.8%
6M
-20.4%
1M
-9.8%
1W
+2.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
18.74
Forward P/E
19.41
PEG Ratio
1.54
P/B Ratio
1.41
P/S Ratio
0.84
EV/Revenue
1.01
EV/EBITDA
9.42
Market Cap
$165.58M

Profitability

Profit margins and return metrics

Profit Margin 5.18%
Operating Margin 6.1%
Gross Margin 39.39%
ROE 9.07%
ROA 5.52%

Growth

Revenue and earnings growth rates

Revenue Growth +3.4%
Earnings Growth +9.4%
Q/Q Revenue Growth +3.44%
Q/Q Earnings Growth +9.9%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.24
Low debt
Current Ratio
4.21
Strong
Quick Ratio
1.43
Good
Cash/Share
$0.94

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
38.2%
Op. Margin
6.1%
Net Margin
3.9%
Total Assets
$0.2B
Liabilities
$0.1B
Equity
$0.1B
Debt/Equity
0.45x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
89%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-23
$0.24
-40.0% surprise
2026-02-26
$0.46
+17.9% surprise
2025-10-21
$0.46
+2.2% surprise
2025-07-23
$1.16
+132.0% surprise

Consumer Defensive Sector Comparison

Comparing ACU against 138 companies in the Consumer Defensive sector (8 bullish, 51 neutral, 79 bearish)
P/E Ratio
18.74
This Stock
vs
34.52
Sector Avg
-45.7% (Discount)
Return on Equity (ROE)
9.07%
This Stock
vs
-22.18%
Sector Avg
-140.9% (Below Avg)
Profit Margin
5.18%
This Stock
vs
-8.73%
Sector Avg
-159.4% (Weaker)
Debt to Equity
0.24
This Stock
vs
1.39
Sector Avg
-82.4% (Less Debt)
Revenue Growth
3.4%
This Stock
vs
135.98%
Sector Avg
-97.5% (Slower)
Current Ratio
4.21
This Stock
vs
2.51
Sector Avg
+67.5% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

MURPHY SUSAN H
Director
Gift
2026-03-03
1,200 shares · $52,896
DRISCOLL PAUL G
Chief Financial Officer
Option Exercise
2026-02-27
15,000 shares · $322,350
JOHNSEN WALTER C
Chief Executive Officer
Option Exercise
2026-02-27
30,000 shares · $644,700
OLSCHAN BRIAN S
President
Option Exercise
2026-02-27
15,000 shares · $373,800
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-23

ACU filed an 8-K on April 23, 2026, likely to announce its first-quarter financial results.

DEF 14A
DEF 14A
2026-03-27

ACU filed a definitive proxy statement (DEF 14A) on March 27, 2026, providing shareholders with necessary information to vote on corporate matters.

10-K
10-K
2026-03-11

ACU submitted its annual 10-K filing on March 11, 2026, which includes sections on business operations, risk factors, and management's discussion and analysis. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
8-K
2026-02-26

ACU filed an 8-K on February 26, 2026, likely to announce its annual financial results.

8-K
8-K
2026-01-22

ACU filed an 8-K on January 22, 2026, likely to announce its quarterly financial results.

10-Q
10-Q
2025-11-06

ACU filed its quarterly Form 10-Q on November 6, 2025. Specific financial highlights and risk factors were not provided in the available metadata.

8-K
8-K
2025-10-21

ACU filed an 8-K on October 21, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-08-06

ACU filed its quarterly Form 10-Q on August 6, 2025. Specific financial highlights and risk factors were not provided in the available metadata.

8-K
8-K
2025-07-23

ACU filed an 8-K on July 23, 2025, likely to announce its second-quarter financial results.

8-K
8-K
2025-07-01
10-Q
10-Q
2025-05-07
8-K
8-K
2025-04-23
8-K
8-K
2025-04-17
8-K
8-K
2025-03-24
DEF 14A
DEF 14A
2025-03-24
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning ACU from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile